ISTA Pharmaceuticals to Participate at Upcoming Investor Conferences

Wednesday, February 24, 2010 General News J E 4

IRVINE, Calif., Feb. 24 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will participate at two investor conferences in March.  ISTA's President and Chief Executive Officer Vicente Anido, Jr., Ph.D., will participate in a panel discussion at the RBC Capital Markets Healthcare Conference at 2:35pm ET on Tuesday, March 2, 2010, in New York City.  ISTA's Chief Financial Officer Lauren Silvernail will present at 2:15pm ET on Tuesday, March 9, 2010, at the Cowen and Company 30th Annual Health Care Conference in Boston, MA.  Both the panel discussion and presentation will be webcast.  

To access live audio broadcasts of these presentations, or the subsequent archived recordings, log onto  Please connect to the website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.


ISTA Pharmaceuticals is the fourth largest branded ophthalmic pharmaceutical business in the U.S. ISTA's four marketed products plus its product candidates include therapies for inflammation, ocular pain, allergy, glaucoma, and dry eye. The Company is developing a strong product pipeline to fuel future growth and market share, supporting its goal to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at

SOURCE ISTA Pharmaceuticals, Inc.



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Endologix to Present at the ROTH 22nd Annual OC Gr...
Close-Up TV News Recognizes Women's Integrated Hea...